COSCIENS Biopharma Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CSCI for the last quarter is 2.34 M USD, and it's 58577.00% higher compared to the previous quarter. The net income of Q2 24 is -1.42 M USD.